Revolution Medicines, Inc. (RVMD) NASDAQ

104.83

+1.14(+1.10%)

Updated at February 24 04:00PM

Currency In USD

Valuation

Market Cap7.34B
Enterprise Value6.93B
P/E Ratio-20.65
PEG Ratio1.39
Price/Sales Ratio0
Price/Book Ratio12.42
Enterprise/Revenue0
Enterprise/EBITDA-20.2

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.43
Return On Equity-0.49

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-677.7M
Net Income-600.09M
Diluted EPS-3.58

Balance Sheet

Total Cash1.93B
Total Cash/Share10.21
Total Debt158.46M
Total Debt/Equity0.1
Current Ratio8.05
Book Value Per Share8.44

Price History

52-Week Change154.64
52-Week High124.49
52-Week Low29.17
Moving Average 50 Days95.29
Moving Average 200 Days58.54

Statistics

Average Volume3.31M
Shares Outstanding193.32M
% Held by Institutions104.62

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A